BRPI0411572A - microemulsões transnasais contendo diazepam - Google Patents

microemulsões transnasais contendo diazepam

Info

Publication number
BRPI0411572A
BRPI0411572A BRPI0411572-4A BRPI0411572A BRPI0411572A BR PI0411572 A BRPI0411572 A BR PI0411572A BR PI0411572 A BRPI0411572 A BR PI0411572A BR PI0411572 A BRPI0411572 A BR PI0411572A
Authority
BR
Brazil
Prior art keywords
microemulsions
diazepam
present
transnasal
alcohol
Prior art date
Application number
BRPI0411572-4A
Other languages
English (en)
Inventor
Yong-Moon Choi
Kwon-Ho Kim
Original Assignee
Sk Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Corp filed Critical Sk Corp
Publication of BRPI0411572A publication Critical patent/BRPI0411572A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MICROEMULSõES TRANSNASAIS CONTENDO DIAZEPAM". A presente invenção refere-se ao diazepam que é administrado intranasalmente, sob a forma de microemulsões específicas que apresentam propriedades vantajosas. As microemulsões são compreendidas de quantidades iguais de ácido graxo e água, com o restante sendo um tensoativo hidrofílico, um solvente polar e um álcool em uma razão em peso de tal modo que o álcool está presente em uma quantidade em peso maior que a dos outros dois. A administração nasal das microemulsões produz uma alta concentração de diazepam no plasma, a uma velocidade próxima da administração intravenosa. As presentes microemulsões são particularmente adequadas ao tratamento imediato e em tempo de pacientes que necessitem tratamento agudo e/ou emergencial de estados de epilepsia e outros ataques induzidos por febre.
BRPI0411572-4A 2003-06-17 2004-06-15 microemulsões transnasais contendo diazepam BRPI0411572A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47928103P 2003-06-17 2003-06-17
PCT/KR2004/001424 WO2004110403A1 (en) 2003-06-17 2004-06-15 Transnasal microemulsions containing diazepam

Publications (1)

Publication Number Publication Date
BRPI0411572A true BRPI0411572A (pt) 2006-08-08

Family

ID=33551875

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411572-4A BRPI0411572A (pt) 2003-06-17 2004-06-15 microemulsões transnasais contendo diazepam

Country Status (12)

Country Link
US (1) US20050002987A1 (pt)
EP (1) EP1633326A4 (pt)
JP (1) JP2006527764A (pt)
KR (1) KR20060012030A (pt)
CN (1) CN100421649C (pt)
AU (1) AU2004246961B2 (pt)
BR (1) BRPI0411572A (pt)
CA (1) CA2529489C (pt)
MX (1) MXPA05014060A (pt)
RU (1) RU2354354C2 (pt)
TW (1) TWI349552B (pt)
WO (1) WO2004110403A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021411A1 (en) * 2005-05-11 2007-01-25 Cloyd James C Supersaturated benzodiazepine solutions and their delivery
TW200824693A (en) 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US7745430B2 (en) * 2006-11-15 2010-06-29 Sk Holdings Co., Ltd. Transnasal anticonvulsive pharmaceutical composition
WO2009046444A2 (en) * 2007-10-05 2009-04-09 Mdrna, Inc. Formulation for intranasal administration of diazepam
KR101517415B1 (ko) * 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
US20160000803A1 (en) * 2013-02-22 2016-01-07 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal administration of benzodiazepines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950664A (en) * 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
EP0532546B1 (en) * 1990-05-10 1998-03-18 Bechgaard International Research And Development A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
DE60038738T2 (de) * 1999-07-26 2009-07-02 Sk Holdings Co., Ltd. Transnasale anticonvulsive zusammensetzungen

Also Published As

Publication number Publication date
RU2354354C2 (ru) 2009-05-10
TW200509943A (en) 2005-03-16
US20050002987A1 (en) 2005-01-06
AU2004246961A1 (en) 2004-12-23
MXPA05014060A (es) 2006-03-17
CN100421649C (zh) 2008-10-01
WO2004110403A1 (en) 2004-12-23
RU2006100112A (ru) 2006-06-27
CA2529489C (en) 2012-01-03
EP1633326A4 (en) 2012-01-18
EP1633326A1 (en) 2006-03-15
JP2006527764A (ja) 2006-12-07
AU2004246961B2 (en) 2010-04-22
CA2529489A1 (en) 2004-12-23
TWI349552B (en) 2011-10-01
KR20060012030A (ko) 2006-02-06
CN1826097A (zh) 2006-08-30

Similar Documents

Publication Publication Date Title
JP7362582B2 (ja) 眼科用水性組成物
KR101089198B1 (ko) 아세틸화 히알루론산 함유 안용 의약조성물
CN103269686B (zh) 隐形眼镜用眼科组合物
BR0012488A (pt) Composição farmacêutica, métodos para melhorar a taxa de absorção de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para melhorar o inìcio do benefìcio terapêutico de um ou mais do que um agente farmaceuticamente ativo em mamìferos, para inibição de gastroirritação em um mamìfero, e para tratamento de mamìferos necessitando do tratamento proporcionado por um ou mais do que um agente farmaceuticamente ativo, e, processo para preparar uma composição farmacêutica
EP3265057B1 (en) Topical formulation
JP2020033386A (ja) 眼科用組成物
JP2009538287A5 (ja) 低粘度グリコサミノグリカンで構成される組成物及び該組成物の間質性膀胱炎の治療での使用
BRPI0411572A (pt) microemulsões transnasais contendo diazepam
BR0109602A (pt) Glóbulos de liberação controlada contendo estavudina
CN105012313B (zh) 5α‑雄甾‑3β,5,6β‑三醇及其类似物在预防或治疗低压缺氧引起的高原病中的应用
JP2005187407A (ja) アレルギー眼疾患用眼科組成物
Kobayashi et al. Dose-and time-dependent liquid sclerosant effects on endothelial cell death
Buys et al. Lipid emulsion therapy: non-nutritive uses of lipid emulsions in anaesthesia and intensive care
BR0317523A (pt) Processo para a preparação de formulações farmacêuticas de combinação utilizando fluidos supercrìticos
SE467340B (sv) Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
CN1160123C (zh) 乌司他丁用于治疗严重急性呼吸综合征的用途及其药物组合物
JP5865623B2 (ja) 皮膚外用剤およびその製造方法
BRPI0416461A (pt) método para o tratamento de episódios de sangramento, formulação farmacêutica, e, uso de um polipeptìdeo fxi
CN105311636B (zh) 一种抗疱疹病毒软膏剂及其制备方法
PT1156830E (pt) Utilizacao de uma emulsao oleo em agua para a preparacao de um medicamento
BR0316770A (pt) Formulação farmacêutica, método de produção da mesma e método de tratamento médico
Nechita et al. Free radicals and antioxidants in ankylosing spondylitis
Hui et al. Continuous veno-venous hemofiltration for septic shock
CN101204390A (zh) 一种紫杉醇静脉注射溶液剂及其应用方案
Kohno et al. Consideration on prevention of phlebitis and venous pain from intravenous prostaglandin E1 administration by adjusting solution pH: in vitro manipulations affecting pH

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SK HOLDINGS CO., LTD. (KR)

Free format text: ALTERADO DE: SK CORPORATION

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE. PAGAR RESTAURACAO.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.